AstraZeneca named ImpactRx to work on measuring the effectiveness of its sales force teams promoting the products Crestor, Nexium and Seroquel to primary care and specialty physicians. ImpactRx measures sales force effectiveness along three dimensions: how sales representatives
execute their plan of action; how well physicians perceive their efforts; and the impact of their activities on new patient treatment decisions.